english.prescrire.org

Welcome to the Prescrire in English website

Reliable, rigorously independent information on treatments and healthcare strategies,
to enable fully informed decision-making. Prescrire is financed by its subscribers.
No grants, no advertising. No shareholders, no sponsors.

In Prescrire's Spotlight

Rivaroxaban 2.5 mg (Xarelto°): no justification for using this anticoagulant after an acute coronary syndrome

1 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
In the October issue of Prescrire International:
adverse effects of boceprevir, colchicine and fluourouracil

1 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
EMA's final policy on access to clinical data: proactive access to some data, but strings attached

16 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Metastastic prostate cancer: enzalutamide is useful for some patients

1 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Drug authorisations: too few patients involved in trials

1 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Tuberculosis: difficult to treat in the case of multidrug-resistance

1 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
  The 2014 "Prescrire Prize" is awarded in Paris to    5 noteworthy books about health and healthcare

02 October 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Mr Juncker, medicines are not just a commodity...

16 September 2014

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Subscribe online for easy access to our database of articles in English

1 September 2014